Furthermore, CEBPB expression displayed a positive correlation with the malignant mesenchymal subtype (MES), as well as the malignant cases of IDH1 wild type and within the TCGA GBM database (Figure 4G-H). This evidence concerns the gene CEBPB and glioblastoma.